|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2100048493 |
|
最近更新日期: Date of Last Refreshed on: |
2021-07-09 12:39:01 |
|
注册时间: Date of Registration: |
2021-07-09 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
上海市孕产妇血栓防止的综合应急能力体系建设策略 |
|
Public title: |
Preventive strategies of venous thromboembolism among pregnant women in Shanghai |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
孕产妇静脉血栓栓塞症质控调研 |
|
Scientific title: |
Quality control and investigation of venous thromboembolism among pregnant women |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
周琼洁 |
研究负责人: |
周琼洁 |
|
Applicant: |
Zhou Qiongjie |
Study leader: |
Zhou Qiongjie |
|
申请注册联系人电话: Applicant telephone: |
13671558865 |
研究负责人电话: Study leader's telephone: |
13671558865 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
zhouqiongjie1732@fckyy.org.cn |
研究负责人电子邮件: Study leader's E-mail: |
zhouqiongjie1732@fckyy.org.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市沈阳路128号 |
研究负责人通讯地址: |
上海市沈阳路128号 |
|
Applicant address: |
No. 128, Road Shenyang |
Study leader's address: |
No. 128, Road Shenyang |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
复旦大学附属妇产科医院 |
||
|
Applicant's institution: |
Obstetrics and gynecology hospital of Fudan University |
||
|
研究负责人所在单位: |
|
||
|
Affiliation of the Leader: |
|
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2020-147 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
复旦大学附属妇产科医院 |
||
|
Name of the ethic committee: |
Obstetrics and gynecology hospital of Fudan University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2020-11-09 00:00:00 |
||
|
伦理委员会联系人: |
鞠丹丹 |
||
|
Contact Name of the ethic committee: |
Jun Dandan |
||
|
伦理委员会联系地址: |
上海市方斜路419号 |
||
|
Contact Address of the ethic committee: |
No. 419, Road Fangxie |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
53513815 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
fckllwyh@fckyy.org.cn |
|
研究实施负责(组长)单位: |
复旦大学附属妇产科医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Obstetrics and gynecology hospital of Fudan University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市方斜路419号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 419, Road Fangxie |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
上海市公共卫生体系建设三年行动计划(2020-2022年)优秀人才培养计划 |
||||||||||||||||||||||
|
Source(s) of funding: |
Shanghai Public Health System Construction Three‐year Action Plan Excellent Talent Training Plan (GWV‐10.2-YQ13) |
||||||||||||||||||||||
|
Target disease: |
venous thromboembolism |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
流行病学研究 |
||||||||||||||||||||||
|
Study type: |
Epidemilogical research |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
根据中国孕产妇独特的发病风险和孕产妇保健体系特征,为了实现 “标准化、多学科衔接、文化建设”目标,本项目目标为建设孕产妇血栓防治综合应急能力体系。拟从孕产妇血栓防治应急管理角度,以期在率先形成特色的孕产妇血栓防治应急体系、标准,为《健康中国2030”规划纲要》提供新的策略。 |
||||||||||||||||||||||
|
Objectives of Study: |
to investigate the current prevention and treatment of venous thromboembolism among pregnant women |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
①从事母婴保健服务的医生;②签署调查知情同意书 |
||||||||||||||||||||||
|
Inclusion criteria |
the obstetric departments have signed the informed consent |
||||||||||||||||||||||
|
排除标准: |
未签署知情同意书者 |
||||||||||||||||||||||
|
Exclusion criteria: |
those who have not signed the informed consent |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2021-08-01 00:00:00至 To 2022-06-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2021-08-01 00:00:00 至 To 2022-06-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
流行病学调查 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
epidemiological cross-sectional study |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
否 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
N/A |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
电子采集和管理系统(Electronic Data Capture, EDC) |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
http://www.chinazhfy.cn/#/./login |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |